Back to Search
LAJOS PUSZTAI, M.D., D.PHIL
M.D., D.PHIL
Medical Oncology Physician
NPI: 1437241510IndividualAccepts Medicare
Education
OTHER
Class of 1987
Research & Publications (20)
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.
PMID 19603265·Breast Cancer Res Treat·2010
8-other
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
PMID 19667268·J Clin Oncol·2009
8-other
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
PMID 19147748·Clin Cancer Res·2009
8-other
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.
PMID 19346299·Oncologist·2009
6-review
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
PMID 19596702·Ann Oncol·2009
8-other
Understanding the structure of aqueous cesium chloride solutions by combining diffraction experiments, molecular dynamics simulations, and reverse Monte Carlo modeling.
PMID 19588949·J Phys Chem B·2009
8-other
Metastatic gene signatures and emerging novel prognostic tests in the management of early stage breast cancer.
PMID 19381845·Clin Exp Metastasis·2009
6-review
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
PMID 19272155·Breast Cancer Res·2009
8-other
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.
PMID 19364972·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20 YORK STREET
NEW HAVEN, CT 06520 - Phone
- (203) 200-5250
Quick Facts
- NPI
- 1437241510
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile